Literature DB >> 34072701

Atypical Clinical Presentation of Laryngopharyngeal Reflux: A 5-Year Case Series.

Jerome R Lechien1,2,3,4, Stéphane Hans2,3, Francois Bobin5, Christian Calvo-Henriquez6, Sven Saussez1,4,7, Petros D Karkos8.   

Abstract

BACKGROUND: Laryngopharyngeal reflux (LPR) is a common disease in otolaryngology characterized by an inflammatory reaction of the mucosa of the upper aerodigestive tract caused by digestive refluxate enzymes. LPR has been identified as the etiological or favoring factor of laryngeal, oral, sinonasal, or otological diseases. In this case series, we reported the atypical clinical presentation of LPR in patients presenting in our clinic with reflux.
METHODS: A retrospective medical chart review of 351 patients with LPR treated in the European Reflux Clinic in Brussels, Poitiers and Paris was performed. In order to be included, patients had to report an atypical clinical presentation of LPR, consisting of symptoms or findings that are not described in the reflux symptom score and reflux sign assessment. The LPR diagnosis was confirmed with a 24 h hypopharyngeal-esophageal impedance pH study, and patients were treated with a combination of diet, proton pump inhibitors, and alginates. The atypical symptoms or findings had to be resolved from pre- to posttreatment.
RESULTS: From 2017 to 2021, 21 patients with atypical LPR were treated in our center. The clinical presentation consisted of recurrent aphthosis or burning mouth (N = 9), recurrent burps and abdominal disorders (N = 2), posterior nasal obstruction (N = 2), recurrent acute suppurative otitis media (N = 2), severe vocal fold dysplasia (N = 2), and recurrent acute rhinopharyngitis (N = 1), tearing (N = 1), aspirations (N = 1), or tracheobronchitis (N = 1). Abnormal upper aerodigestive tract reflux events were identified in all of these patients. Atypical clinical findings resolved and did not recur after an adequate antireflux treatment.
CONCLUSION: LPR may present with various clinical presentations, including mouth, eye, tracheobronchial, nasal, or laryngeal findings, which may all regress with adequate treatment. Future studies are needed to better specify the relationship between LPR and these atypical findings through analyses identifying gastroduodenal enzymes in the inflamed tissue.

Entities:  

Keywords:  atypical; clinical; diagnosis; laryngopharyngeal; management; nasal; otological; reflux; respiratory; treatment

Year:  2021        PMID: 34072701     DOI: 10.3390/jcm10112439

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  30 in total

Review 1.  Laryngopharyngeal Reflux and Voice Disorders: A Multifactorial Model of Etiology and Pathophysiology.

Authors:  Jerome R Lechien; Sven Saussez; Bernard Harmegnies; Camille Finck; James A Burns
Journal:  J Voice       Date:  2017-04-21       Impact factor: 2.009

2.  Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Authors:  Jerome R Lechien; Sven Saussez; Antonio Schindler; Petros D Karkos; Abdul Latif Hamdan; Bernard Harmegnies; Lisa G De Marrez; Camille Finck; Fabrice Journe; Marianne Paesmans; Michael F Vaezi
Journal:  Laryngoscope       Date:  2018-12-30       Impact factor: 3.325

3.  Detecting nasopharyngeal reflux: a novel pH probe technique.

Authors:  Joseph D Brunworth; Rohit Garg; Hossein Mahboubi; Brandon Johnson; Hamid R Djalilian
Journal:  Ann Otol Rhinol Laryngol       Date:  2012-07       Impact factor: 1.547

Review 4.  Proximal reflux: biochemical mediators, markers, therapeutic targets, and clinical correlations.

Authors:  Miles J Klimara; Derrick R Randall; Jacqueline Allen; Edgar Figueredo; Nikki Johnston
Journal:  Ann N Y Acad Sci       Date:  2020-05-13       Impact factor: 5.691

Review 5.  Pepsin as a marker of extraesophageal reflux.

Authors:  Tina L Samuels; Nikki Johnston
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-03       Impact factor: 1.547

6.  Oral manifestations in gastroesophageal reflux disease.

Authors:  A Preetha; D Sujatha; Bharathi A Patil; Sushmini Hegde
Journal:  Gen Dent       Date:  2015 May-Jun

7.  PepsinA as a Marker of Laryngopharyngeal Reflux Detected in Chronic Rhinosinusitis Patients.

Authors:  Jian-Jun Ren; Yu Zhao; Jing Wang; Xue Ren; Yang Xu; Wenlong Tang; Zhaoping He
Journal:  Otolaryngol Head Neck Surg       Date:  2017-05       Impact factor: 3.497

8.  Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring.

Authors:  Jerome R Lechien; Francois Bobin; Vinciane Muls; Mihaela Horoi; Marie-Paule Thill; Didier Dequanter; Alexandra Rodriguez; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-02       Impact factor: 2.503

9.  The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance-pH monitoring in patients with acid, non-acid and mixed laryngopharyngeal reflux.

Authors:  Jérôme R Lechien; Francois Bobin; Vinciane Muls; Francois Mouawad; Didier Dequanter; Mihaela Horoi; Marie-Paule Thill; Alexandra Rodriguez Ruiz; Sven Saussez
Journal:  Clin Otolaryngol       Date:  2021-02-10       Impact factor: 2.597

10.  Laryngotracheal Microbiota in Adult Laryngotracheal Stenosis.

Authors:  Alexander T Hillel; Sharon S Tang; Camila Carlos; Joseph H Skarlupka; Madhu Gowda; Linda X Yin; Kevin Motz; Cameron R Currie; Garret Suen; Susan L Thibeault
Journal:  mSphere       Date:  2019-05-01       Impact factor: 4.389

View more
  1 in total

Review 1.  Clinical Update Findings about pH-Impedance Monitoring Features in Laryngopharyngeal Reflux Patients.

Authors:  Jerome R Lechien
Journal:  J Clin Med       Date:  2022-06-01       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.